Evaluation of the in vivo efficacy of intramuscularly administered ceftaroline fosamil, a novel cephalosporin, against a methicillin-resistant Staphylococcus aureus strain in a rabbit endocarditis model

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 10, 2010, Pages 2264-2265

  Jacqueline, Cédric ^a   Caillon, Jocelyne ^a   Batard, Eric ^a   Le Mabecque, Virginie ^a   Amador, Gilles ^a   Ge, Yigong ^b   Biek, Donald ^b   Potel, Gilles ^a  

^a UNIVERSITÉ DE NANTES   (France)

^b Cerexa Inc   (United States)

Author keywords

Animal model; MRSA; Outpatient antibiotic therapy

Indexed keywords

CEFTAROLINE FOSAMIL; TEICOPLANIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; AORTA VALVE DISEASE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD CULTURE; CONTROLLED STUDY; ENDOCARDITIS; FEMALE; IN VIVO STUDY; INOCULATION; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RABBIT;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL LOAD; CEPHALOSPORINS; DISEASE MODELS, ANIMAL; ENDOCARDITIS, BACTERIAL; ENDOCARDIUM; FEMALE; INJECTIONS, INTRAMUSCULAR; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; RABBITS; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME;

EID: 77957241721     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq328     Document Type: Letter

References (7)

1. Sader HS, Fritsche TR, Kaniga K et al. Antimicrobial activity and spectrum of PPI-0903M (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strains. Antimicrob Agents Chemother 2005; 49: 3501-12.
2. Klevens RM, Morrison MA, Nadle J et al. for the Active Bacterial Core surveillance (ABCs) MRSA Investigators. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007; 298: 1763-71.
3. Ge Y, Maynard D, Rickert DE. Comparative pharmacokinetics of ceftaroline in rats, rabbits, and monkeys following a single intravenous or intramuscular injection. Antimicrob Agents Chemother 2010; 54: 912-4.
4. Jacqueline C, Asseray N, Batard E et al. In vivo efficacy of linezolid in combination with gentamicin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents 2004; 24: 393-6.
5. Perlman BB, Freedman LR. Experimental endocarditis, II: staphylococcal infection of the aortic valve following placement of a polyethylene catheter in the left side of the heart. Yale J Biol Med 1971; 44: 206-13.
6. Andes D, Craig WA. Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target. Antimicrob Agents Chemother 2006; 50: 1376-83.
7. Jacqueline C, Caillon J, Le Mabecque V et al. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model. Antimicrob Agents Chemother 2007; 51: 3397-400.